NICE rejects combination treatment for multiple myeloma
August 27, 2021Medical Communications
NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …
CARMAT’s artificial heart commercially implanted successfully for third time
August 27, 2021Medical Communications
CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …
New PPE mask range can begin to kill SARS-CoV-2 on contact
August 27, 2021Medical Communications
A new PPE mask range has been launched that can begin to kill SARS-CoV-2 and other viruses and pathogens on …
Genetic cause of endometriosis identified alongside potential drug target
August 26, 2021New research, published in Science Translational Medicine, has identified the genetic cause of endometriosis which in turn has identified a …
Malaria sickness could be cut by 70%, study finds
August 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
Positive Phase III trial results for AstraZeneca in flushing copper from tissues
August 26, 2021AstraZeneca’s ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments.Results from the FoCus Phase III trial …
NHS blood tests halted due to vial shortages
August 26, 2021The NHS has suspended some blood testing due to a shortage in collection tube supplies following warnings from Becton Dickinson …
NHS England planning for possible jab roll out to 12-15 year-olds
August 26, 2021NHS England is preparing for a possible extension of the COVID vaccination programme to all 12 to 15-year-olds.This will be …
Trial planned to investigate ketamine in treatment-resistant depression
August 25, 2021Research and Development
HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …
Stelis Biopharma appoints Mark Womack as new CEO
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …
PureTech appoints Julie Krop as Chief Medical Officer
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …
Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …
RareCan appoints Dr Anita Cooper as Non-Executive Director
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …
Laura Steele appointed President and General Manager for Lilly UK
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …
Medical cannabis: The next innovation in oncology?
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …
Pharma disputes, fines, and the work of the CMA
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …
One-time gene therapy sees promising results in children with AADC deficiency
August 25, 2021Research and Development
A pioneering approach to gene therapy delivery has been published in the European Molecular Biology Organization Journal on Wednesday, wherein …
Generic asthma inhaler to offer NHS significant savings
August 25, 2021Research and Development
Luforbec 100/6 pMDI, the first branded generic alternative to Fostair 100/6 pMDI, to treat adult asthma and severe chronic obstructive …
Protection from COVID-19 vaccines starts to wane within six months
August 25, 2021Research and Development
Researchers are starting to see that protection from the COVID-19 vaccines begins to wane within sixe months of receiving a …
Pfizer to buy Trillium for $2.26 billion
August 25, 2021Research and Development
Pfizer will buy Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, for $2.26 billion.Trillium’s …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
